Last updated: 2026-05-19
How TMS Acts on the Nervous System
Chronic headache, insomnia, and nervous system hypersensitivity often cannot be resolved by simply suppressing symptoms. TMS (Transcranial Magnetic Stimulation) is a non-invasive neuromodulation therapy that uses electromagnetic fields applied outside the scalp to stimulate neural circuits. It can directly target central sensitization circuits (a state in which the central nervous system becomes excessively reactive) and autonomic nervous system imbalances that medication alone may not fully address.
TMS works on the principle of Faraday's law of electromagnetic induction. A strong electrical current passes through a coil placed against the scalp, generating a magnetic field within milliseconds. That field passes through the skull and reaches cortical neurons, altering the distribution of ions across the cell membrane and activating the nerve cells. No incision or electrode implantation is required.
Single-pulse stimulation is used for diagnostic purposes, while treatment relies on repetitive TMS (rTMS). The frequency of stimulation determines its effect on the cortex. High-frequency stimulation at ten or more pulses per second increases cortical excitability, while low-frequency stimulation at one pulse per second suppresses an overactive cortex.
The mechanism behind rTMS is synaptic plasticity — the gradual change in the strength of connections between neurons. Research suggests that rTMS can induce neural reorganization similar to long-term potentiation (LTP) and long-term depression (LTD), two well-established processes in neuroscience. A single session produces only a transient effect, but studies report stable changes in neural connectivity when sessions are repeated over several weeks. (Knotkova Helena et al., 2021)
Because TMS is non-invasive, treatment is straightforward. Outpatient sessions require no general anesthesia, and patients can return to their daily routine immediately — a practical advantage that also makes it realistic to sustain the repeated sessions needed over several weeks.
Chronic Headache
Migraine and tension : type headache are distinct conditions, but they share a common neurophysiological phenomenon: central sensitization. In this state, even weak stimuli that would not normally cause pain become amplified into pain, and even light touch on the scalp can trigger intense discomfort — a phenomenon called allodynia. The longer headaches persist, the deeper the sensitization becomes.
The occipital cortex and prefrontal cortex have received particular attention. Brain imaging studies of chronic migraine patients frequently show patterns of elevated cortical excitability. Sensitivity to light and sound increases, and as attack frequency rises, the cortex appears unable to rest.
TMS modulates the excitability of this overactive cortex. Low-frequency rTMS has been studied as a way to suppress overactivated cortical areas, and the approach is closer to headache prevention (reducing attack frequency and intensity) than to immediate pain relief after an attack has begun. The 2022 American Headache Society consensus statement identifies neuromodulation devices as a complementary option in migraine management, citing devices such as single-pulse TMS (sTMS). (Ailani Jessica et al., 2022) This means neuromodulation can be considered alongside existing treatments depending on a patient's condition and response, rather than being designated a primary preventive therapy.
Many patients find that medication alone does not provide adequate headache control — whether because preventive drugs have lost effectiveness or because side effects such as weight gain, drowsiness, or cognitive dulling require dose reductions. TMS may offer a way to directly modulate cortical excitability in these situations. (Knotkova Helena et al., 2021) The speed and degree of response vary between individuals, and outcomes can differ based on baseline cortical excitability levels and headache subtype — something worth understanding before starting treatment.
Insomnia and Nervous System Hyperarousal
Viewing insomnia purely as "difficulty sleeping" can delay effective treatment. Sleep research points to hyperarousal bias — a state in which the nervous system remains persistently overactivated — as the core issue in insomnia. The circuits connecting the prefrontal cortex and the limbic system (the brain's emotional processing center) stay switched on even when the body should be winding down for sleep.
This hyperarousal leaves a mark on the autonomic nervous system. When the sympathetic nervous system dominates, heart rate stays elevated, body temperature fails to drop, and the transition into deep non-REM (NREM) sleep is delayed. Sleep architecture deteriorates and deep sleep becomes less frequent. Over time, daytime fatigue accumulates and the hyperarousal on the following night intensifies — a self-reinforcing cycle.
rTMS targets this cycle directly. The dorsolateral prefrontal cortex (DLPFC) is one of the most studied targets in insomnia and arousal regulation research. Low-frequency stimulation is associated with reducing overactivity in this region, but insomnia research also examines protocols applying high-frequency stimulation to specific areas. The stimulation protocol is tailored to each patient's neurological state, target symptoms, and coexisting conditions. (Knotkova Helena et al., 2021) Unlike sleep medications, TMS does not suppress consciousness. The goal is to modulate the excitability of the neural circuits driving the hyperarousal state.
Clinicians frequently encounter patients who have both chronic pain and insomnia at the same time. When the nervous system is sensitized, pain disrupts sleep, and sleep deprivation lowers the pain threshold — a vicious cycle. This pattern is especially prominent in patients with neuropathic pain (pain caused by nerve injury or dysfunction) that does not respond adequately to medication, and it is one of the rationales for considering neuromodulation therapy. (da Cunha Pedro Henrique Martins et al., 2024) The evidence base for TMS in insomnia is still growing compared to that for chronic headache, and individual responses can vary — a fact worth acknowledging honestly.
The Treatment Process and Safety
TMS does not require hospitalization.
The patient sits in a chair while a coil is positioned against a specific area of the scalp. When stimulation is delivered, it feels like a tapping sensation on the scalp, accompanied by an audible clicking from the coil vibrating. The experience is closer to mild discomfort than pain, though first-time patients may find it unfamiliar. Each session takes approximately 20 to 40 minutes.
Some patients experience mild scalp discomfort or a light headache immediately after the session. These effects typically resolve on their own within a few hours. Because the stimulation is localized to a specific cortical area rather than acting throughout the entire nervous system, the burden of systemic side effects is low compared to medication. Most patients can go home and resume normal activities right after the session, though individual responses vary. (Knotkova Helena et al., 2021)
Treatment is not completed in a single session. Sustaining stable synaptic plasticity requires repeated sessions over several weeks. A common schedule is two sessions per week for four to six weeks, but the total number and frequency are adjusted based on the target symptoms and the patient's response.
Certain contraindications must be assessed beforehand. TMS is not appropriate for patients with intracranial metallic implants (such as aneurysm coils or clips), active epilepsy, or pregnancy. The presence of a cardiac pacemaker is also reviewed during the initial medical history. These factors are confirmed through a detailed pre-treatment interview and medical history review. In patients without these contraindications, the reported rate of serious adverse events with TMS is low.
What to Consider When Choosing This Treatment
TMS is not suitable for every patient in the same way. Understanding the clinical context helps set realistic expectations and build a practical plan.
For chronic headache, TMS is considered as a preventive treatment. Patients currently taking preventive medications may be able to use TMS alongside them, and it may serve as an alternative approach for those who have developed tolerance to medications or need to reduce doses because of side effects. Research into which patients respond best — based on baseline cortical excitability, headache phenotype, and coexisting conditions — is ongoing, and a reliable predictive model has yet to emerge.
For insomnia and nervous system sensitization, an integrated strategy is more realistic than TMS alone. Combining TMS with sleep hygiene correction, cognitive behavioral therapy for insomnia (CBT-I), and medication when needed is an approach used in clinical practice. Even if TMS shifts the regulation of neural circuits, those changes are unlikely to last unless sleep behaviors and daily patterns change alongside them.
When neuropathic pain is also present, the evidence for neuromodulation is accumulating, but it is more reasonable to set partial improvement as the goal rather than complete resolution. (da Cunha Pedro Henrique Martins et al., 2024) A significant number of patients find that medications alone do not provide sufficient relief, and the evidence for combining neuromodulation as a complementary approach continues to build.
The broader direction of neurological care is shifting — away from suppressing symptoms and toward targeting the functional state of neural circuits themselves. (Knotkova Helena et al., 2021) From a longevity medicine perspective, chronic headache, insomnia, and nervous system hyperreactivity are not just short-term symptoms; they may signal that the nervous system is gradually losing its optimal regulatory capacity. Restoring that capacity ( rather than simply managing symptoms ) is the goal that TMS and other neuromodulation therapies pursue.
Individual responses depend on baseline neurological state, stimulation site, protocol design, and concurrent treatments. When considering TMS, sharing a full picture of your current symptoms and treatment history with your care team, and working together to set goals and a schedule, is the essential first step.
This content is provided for informational purposes only and may not apply to every individual situation. Please consult a specialist for an accurate diagnosis and personalized treatment plan.
References
- Knotkova Helena, Hamani Clement, Sivanesan Eellan (2021). Neuromodulation for chronic pain. Lancet. PMID: 34062145
- Ailani Jessica, Burch Rebecca C, Robbins Matthew S (2022). The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. PMID: 34160823
- da Cunha Pedro Henrique Martins, Lapa Jorge Dornellys da Silva, Hosomi Koichi (2024). Neuromodulation for neuropathic pain. Int Rev Neurobiol. PMID: 39580221
Frequently Asked Questions
Changes in neural circuit regulation achieved through TMS have been reported to persist for a period of time after treatment ends. Studies have observed effects lasting from several weeks to several months in chronic headache and insomnia, though the duration can vary based on an individual's baseline neurological state and coexisting conditions. For this reason, clinicians typically review a maintenance treatment schedule after the initial course.
TMS is not appropriate for patients with intracranial metallic implants (such as aneurysm clips or coils) or those with implanted electronic medical devices such as deep brain stimulators or cochlear implants. Patients with a history of epilepsy require careful review of the stimulation protocol. Pregnancy and recent brain surgery are also factors that must be discussed with the care team before proceeding.
A schedule of two to three sessions per week over several weeks is commonly used in clinical practice. The total number of sessions and the stimulation site can differ depending on whether the treatment goal is chronic headache prevention or modulation of insomnia and nervous system hyperreactivity. Adjusting the schedule based on interim assessments of individual response is the recommended approach.
Sleep medications primarily work by acting on inhibitory receptors in the central nervous system to lower arousal levels and induce sleep. TMS, by contrast, modulates the excitability of the neural circuits that drive hyperarousal in the first place — a fundamentally different point of action that does not share the same pathways for dependence or tolerance that can develop with receptor-targeted medications. Because the two approaches act at different points, using them together or sequentially may be considered depending on the clinical situation.
TMS is a non-invasive procedure, and in most cases it can be used alongside existing medications without interruption. Whether any medication adjustment is needed depends on the type and dose of current medications and the treatment goals, and this is determined individually by the care team. Stopping medications on your own can worsen symptoms, so any changes should always be made in consultation with your doctor.